Chesnara PLC is set to complete its acquisition of Scottish Widows Europe by the end of 2026, adding about €1.7 billion in assets and 46,000 policies. The deal provides Chesnara a Luxembourg base for further European expansion. Despite market volatility, Chesnara reported a 79% rise in operating capital generation and a 46% increase in adjusted operating profit in the first half of the year. The company plans to focus on integration work and continues to pursue new acquisition opportunities with a strong pipeline.
Since 2022, the amount of credit card debt that is 90 days overdue has almost doubled, indicating growing financial stress among borrowers. However, the rate of new delinquencies has not increased, suggesting that while existing overdue balances are ...
Capital One experienced a significant 26% increase in purchase volume, highlighting strong growth in its recent franchise acquisition. In contrast, the legacy Discover card volume saw minimal growth, rising less than 2%. This disparity underscores th...
AbbVie has submitted an application to the European Medicines Agency (EMA) for approval of SKYRIZI (risankizumab) as a subcutaneous induction treatment for adults with moderately to severely active Crohn's disease. This follows positive results from ...
Amgen and AstraZeneca announced that TEZSPIRE (tezepelumab-ekko) demonstrated significant and sustained improvements in eosinophilic esophagitis (EoE) patients in the Phase 3 CROSSING trial, with benefits maintained through 52 weeks. The drug improve...
VEEM Limited announced its FY 2026 financial results with revenue reaching $51.7 million, hitting the upper end of guidance despite lower gyro sales and delays in ASC orders. EBITDA was $3.6 million, within the expected range but down from the previo...
